AMR vs Eswatini: Estimated antiretroviral therapy coverage among people living with HIV
AMR
71.0%
in 2025
Eswatini
95.0%
in 2025
AMR rank
4th
Eswatini rank
5th
Estimated antiretroviral therapy coverage among people living with HIV over time
- AMR
- Eswatini
How they compare
Eswatini currently reports 95.0% against 71.0% in AMR, a difference of 24.0%.
That makes Eswatini's figure about 1.3 times AMR's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was AMR ahead.
AMR ranks 4th and Eswatini ranks 5th of 13 groups.
Across the 3 decades both report, AMR averaged higher in 1 and Eswatini in 2.
Head to head by decade
| Decade | AMR | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.9% | 7.6% | 18.3% | AMR |
| 2010s | 51.4% | 57.5% | 6.1% | Eswatini |
| 2020s | 67.7% | 91.8% | 24.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, AMR or Eswatini?
- Eswatini, at 95.0% against 71.0% in AMR as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between AMR and Eswatini?
- 24.0%, with Eswatini ahead.
- How many years of comparable data are there for AMR and Eswatini?
- 26 years are reported by both, from 2000 to 2025.
- How do AMR and Eswatini rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- AMR ranks 4th and Eswatini ranks 5th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.